SEC Form 4 · accession 0001193125-26-274171
Korro Bio, Inc. · KRRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd Chappell
Officer — Chief Operating Officer
Period of report
Jun 16, 2026
Accepted (ET)
Jun 17, 2026 · 4:14 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001703647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jun 16, 2026 | S | 3,168 | $10.83 | D | 16,964 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the mandatory sale of shares of common stock solely to satisfy tax withholding obligations incurred upon vesting and settlement of a restricted stock unit (RSU) granted under the Issuer's 2023 Stock Option and Incentive Plan (the 2023 Plan).
- F2The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $10.58 to $11.35, inclusive. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request.
- F3Includes 10,066 shares of common stock issuable upon settlement of a RSU granted under the 2023 Plan that will vest on December 15, 2026 subject to the reporting person maintaining a continuous Service Relationship (as defined in the 2023 Plan) through such date.